UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 125

Sortiert nach

Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats

Endocrinology (Philadelphia), 2016-01, Vol.157 (1), p.207-219

2016

Volltextzugriff (PDF)

A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis

Journal of ethnopharmacology, 2005-01, Vol.96 (1), p.133-138

2005

Volltextzugriff (PDF)

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Cancer research (Chicago, Ill.), 2021-09, Vol.81 (18), p.4736-4750

2021

Volltextzugriff (PDF)

The biology and clinical implications of prostate cancer dormancy and metastasis

Journal of Molecular Medicine, 2016-03, Vol.94 (3), p.259-265

2016

Volltextzugriff (PDF)

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer

Asian Journal of Urology, 2016-10, Vol.3 (4), p.223-228

2016

Volltextzugriff (PDF)

Exposure of Human Prostaspheres to Bisphenol A Epigenetically Regulates SNORD Family Noncoding RNAs via Histone Modification

Endocrinology (Philadelphia), 2015-11, Vol.156 (11), p.3984-3995

2015

Volltextzugriff (PDF)

Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study

Clinical genitourinary cancer, 2023-12, Vol.21 (6), p.669-678

2023

Volltextzugriff (PDF)

Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer

Endocrine-related cancer, 2014-12, Vol.21 (6), p.903-914

2014

Volltextzugriff (PDF)

Estrogen receptor-beta and breast cancer: Translating biology into clinical practice

Steroids, 2012-06, Vol.77 (7), p.727-737

2012

Volltextzugriff (PDF)

The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow

Drug discovery today. Technologies, 2014-03, Vol.11, p.41-47

2014

Volltextzugriff (PDF)

Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy

The Journal of urology, 2016-06, Vol.195 (6), p.1760-1766

2016

Volltextzugriff (PDF)

Hypomethylation of Dual Specificity Phosphatase 22 Promoter Correlates With Duration of Service in Firefighters and Is Inducible by Low-Dose Benzo[a]Pyrene

Journal of occupational and environmental medicine, 2012-07, Vol.54 (7), p.774-780

2012

Volltextzugriff (PDF)

Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

JCI insight, 2019-07, Vol.5 (13)

2019

Volltextzugriff (PDF)

Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy

Urologic oncology, 2018-07, Vol.36 (7), p.342.e7-342.e14

2018

Volltextzugriff (PDF)

Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion

Molecular and cellular endocrinology, 2012-07, Vol.358 (1), p.27-35

2012

Volltextzugriff (PDF)

Quantitative Image Analysis of Epithelial and Stromal Area in Histological Sections of Colorectal Cancer: An Emerging Diagnostic Tool

BioMed research international, 2015-01, Vol.2015, p.569071-9

2015

Volltextzugriff (PDF)

Anti-Proliferative effect of ursolic acid on multidrug resistant hepatoma cells R-HepG2 by apoptosis induction

Cancer biology & therapy, 2007-09, Vol.6 (9), p.1377-1385

2007

Volltextzugriff (PDF)

Saxifragifolin B from Androsace umbellata induced apoptosis on human hepatoma cells

Biochemical and biophysical research communications, 2007-10, Vol.362 (3), p.759-765

2007

Volltextzugriff (PDF)

MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

MP65-02 AIM HIGH: EPIGENETIC MODULATION AND IMMUNE STIMULATION IN BLADDER CANCER

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Molecular subtype variation within metastasis of urothelial carcinoma

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.471-471

2021

Volltextzugriff (PDF)

PD53-09 ANTIBODY DRUG CONJUGATES AND VARIANT HISTOLOGY MUSCLE-INVASIVE BLADDER CANCER: ARE THE TARGETS PRESENT IN PRIMARY AND/OR METASTATIC TUMORS?

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

AIM HIGH: EPIGENETIC MODULATION AND IMMUNE STIMULATION IN BLADDER CANCER

Urologic oncology, 2024-03, Vol.42, p.S34-S34

2024

Volltextzugriff (PDF)

PD10-06 A PHASE 1/2 STUDY OF RAPAMYCIN AND CISPLATIN/GEMCITABINE FOR TREATMENT OF PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (NCT01938573)

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

MP06-05 UROTHELIAL CANCER RAPID AUTOPSY PROGRAM: BIOSPECIMENS AND PATIENT-DERIVED PRECLINICAL MODELS

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

26 – 50 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(125)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(53)
Humans
(48)
Male
(31)
Animals
(21)
Technology
(17)
Oncology
(16)
Environmental Sciences
(14)
Environmental Sciences & Ecology
(14)
Engineering
(12)
Mice
(11)
Prostate Cancer
(11)
Prostatic Neoplasms - Metabolism
(11)
Metastasis
(10)
Middle Aged
(10)
Science & Technology - Other Topics
(10)
Cancer
(9)
Female
(9)
Prostatic Neoplasms - Pathology
(9)
Prostatic Neoplasms, Castration-Resistant - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats

A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

The biology and clinical implications of prostate cancer dormancy and metastasis

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer

Exposure of Human Prostaspheres to Bisphenol A Epigenetically Regulates SNORD Family Noncoding RNAs via Histone Modification

Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study

Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer

Estrogen receptor-beta and breast cancer: Translating biology into clinical practice

The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow

Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy

Hypomethylation of Dual Specificity Phosphatase 22 Promoter Correlates With Duration of Service in Firefighters and Is Inducible by Low-Dose Benzo[a]Pyrene

Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy

Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion

Quantitative Image Analysis of Epithelial and Stromal Area in Histological Sections of Colorectal Cancer: An Emerging Diagnostic Tool

Anti-Proliferative effect of ursolic acid on multidrug resistant hepatoma cells R-HepG2 by apoptosis induction

Saxifragifolin B from Androsace umbellata induced apoptosis on human hepatoma cells

MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER

MP65-02 AIM HIGH: EPIGENETIC MODULATION AND IMMUNE STIMULATION IN BLADDER CANCER

Molecular subtype variation within metastasis of urothelial carcinoma

PD53-09 ANTIBODY DRUG CONJUGATES AND VARIANT HISTOLOGY MUSCLE-INVASIVE BLADDER CANCER: ARE THE TARGETS PRESENT IN PRIMARY AND/OR METASTATIC TUMORS?

AIM HIGH: EPIGENETIC MODULATION AND IMMUNE STIMULATION IN BLADDER CANCER

PD10-06 A PHASE 1/2 STUDY OF RAPAMYCIN AND CISPLATIN/GEMCITABINE FOR TREATMENT OF PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (NCT01938573)

MP06-05 UROTHELIAL CANCER RAPID AUTOPSY PROGRAM: BIOSPECIMENS AND PATIENT-DERIVED PRECLINICAL MODELS

Suchergebnisse filtern